Company filings profile · CIK 0001787740

Valion Bio, Inc. — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for Valion Bio, Inc. (VBIO): 25 filings in the last 90 days vs 26 in the prior 90 (filing-velocity steady · 0.96×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Sep 24, 2026. Source-linked, daily-refreshed.

Material 8-K events — Valion Bio, Inc.

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
Sep 23, 2026Departure/Election of Directors or Officers; Regulation FD Disclosure; Financial Statements and Exhibits
Sep 1, 2026Entry into a Material Agreement; Unregistered Sale of Securities; Departure/Election of Directors or Officers; Regulation FD Disclosure; Financial Statements and Exhibits
Aug 27, 2026Item 3.03; Amendments to Bylaws/Charter; Regulation FD Disclosure; Financial Statements and Exhibits
Aug 17, 2026Unregistered Sale of Securities; Departure/Election of Directors or Officers; Item 5.07; Other Events; Financial Statements and Exhibits
Aug 6, 2026Entry into a Material Agreement; Unregistered Sale of Securities; Other Events
Jul 14, 2026Regulation FD Disclosure; Financial Statements and Exhibits
Jun 18, 2026Unregistered Sale of Securities; Other Events
Jun 3, 2026Departure/Election of Directors or Officers; Item 5.07; Financial Statements and Exhibits
May 14, 2026Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits
May 4, 2026Departure/Election of Directors or Officers; Regulation FD Disclosure; Financial Statements and Exhibits
Apr 23, 2026Amendments to Bylaws/Charter; Financial Statements and Exhibits

Watch Valion Bio, Inc. automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Insider transactions (Form 4 / 3 / 5)

FiledForm
Sep 17, 20263
Sep 17, 20263
Jun 18, 20264
May 20, 20264
May 4, 20264
May 4, 20263
Apr 20, 20264
Apr 2, 20264
Mar 19, 20264
Feb 20, 20264

Recent filings

FiledFormDetail
Sep 23, 20268-K Departure/Election of Directors or Officers; Regulation FD Disclosure; Financial Statements and Exhibits
Sep 17, 20263
Sep 17, 20263
Sep 4, 2026SCHEDULE 13G/A
Sep 3, 2026SCHEDULE 13D/A
Sep 2, 2026SCHEDULE 13D/A
Sep 1, 20268-K Entry into a Material Agreement; Unregistered Sale of Securities; Departure/Election of Directors or Officers; Regulation FD Disclosure; Financial Statements and Exhibits
Aug 27, 2026SCHEDULE 13D/A
Aug 27, 20268-K Item 3.03; Amendments to Bylaws/Charter; Regulation FD Disclosure; Financial Statements and Exhibits
Aug 24, 2026SCHEDULE 13D/A
Aug 24, 2026RW REGISTRATION WITHDRAWAL REQUEST
Aug 20, 20268-K/A Item 5.07
Aug 19, 2026SCHEDULE 13D/A
Aug 17, 20268-K Unregistered Sale of Securities; Departure/Election of Directors or Officers; Item 5.07; Other Events; Financial Statements and Exhibits
Aug 14, 2026SCHEDULE 13D/A
Aug 14, 202610-Q FORM 10-Q
Aug 12, 2026EFFECT Item ; Item ; Item
Aug 11, 2026SCHEDULE 13D/A
Aug 6, 20268-K Entry into a Material Agreement; Unregistered Sale of Securities; Other Events
Aug 3, 2026SCHEDULE 13D
Jul 17, 2026DEF 14A DEFINITIVE PROXY STATEMENT
Jul 17, 2026S-1 DRAFT REGISTRATION STATEMENT
Jul 17, 2026SCHEDULE 13G
Jul 14, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
Jul 7, 2026PRE 14A PRELIMINARY PROXY
Jun 18, 20264
Jun 18, 20268-K Unregistered Sale of Securities; Other Events
Jun 5, 2026S-8 FORM S-8
Jun 5, 2026S-8 FORM S-8
Jun 3, 20268-K Departure/Election of Directors or Officers; Item 5.07; Financial Statements and Exhibits
May 20, 20264
May 14, 202610-Q FORM 10-Q
May 14, 20268-K Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits
May 8, 2026SCHEDULE 13G/A
May 4, 20264
May 4, 20263
May 4, 20268-K Departure/Election of Directors or Officers; Regulation FD Disclosure; Financial Statements and Exhibits
Apr 30, 2026ARS ANNUAL REPORT
Apr 30, 2026DEF 14A DEFINITIVE PROXY STATEMENT
Apr 23, 20268-K Amendments to Bylaws/Charter; Financial Statements and Exhibits